These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 11672458

  • 1. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A, Hulthe J, Rosengren A, Wiklund O, Wilhelmsen L.
    Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME, McInerney D, Fraser A, Johnson AH, Collins PB, Owens D, Tomkin GH.
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [Abstract] [Full Text] [Related]

  • 3. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H, Hallmans G, Jansson JH, Boman K, Wikström M, de Faire U, Frostegård J.
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [Abstract] [Full Text] [Related]

  • 4. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G.
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [Abstract] [Full Text] [Related]

  • 5. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [Abstract] [Full Text] [Related]

  • 6. [Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].
    González M, Rojas N, Durán D, Schade A, Campos R, Milos C.
    Rev Med Chil; 1997 Aug; 125(8):879-85. PubMed ID: 9567390
    [Abstract] [Full Text] [Related]

  • 7. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 8. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia.
    Jain M, Sawhney H, Aggarwal N, Vashistha K, Majumdhar S.
    J Obstet Gynaecol Res; 2004 Jun 09; 30(3):188-92. PubMed ID: 15210040
    [Abstract] [Full Text] [Related]

  • 9. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA, Hadzhimitova V, Ribarov S.
    Gen Physiol Biophys; 2000 Mar 09; 19(1):103-13. PubMed ID: 10930142
    [Abstract] [Full Text] [Related]

  • 10. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
    Doo YC, Han SJ, Lee JH, Cho GY, Hong KS, Han KR, Lee NH, Oh DJ, Ryu KH, Rhim CY, Lee KH, Lee Y.
    Am J Cardiol; 2004 Mar 01; 93(5):554-8. PubMed ID: 14996578
    [Abstract] [Full Text] [Related]

  • 11. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
    Gonçalves I, Gronholdt ML, Söderberg I, Ares MP, Nordestgaard BG, Bentzon JF, Fredrikson GN, Nilsson J.
    Arterioscler Thromb Vasc Biol; 2005 Jun 01; 25(6):1250-5. PubMed ID: 15831809
    [Abstract] [Full Text] [Related]

  • 12. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP, Zhou X.
    J Cardiovasc Pharmacol; 2007 Apr 01; 49(4):246-52. PubMed ID: 17438410
    [Abstract] [Full Text] [Related]

  • 13. Considerable disturbances of cardiovascular risk factors in women with diabetes and myocardial infarction.
    Dotevall A, Wilhelmsen L, Lappas G, Rosengren A.
    J Diabetes Complications; 2005 Apr 01; 19(1):26-34. PubMed ID: 15642487
    [Abstract] [Full Text] [Related]

  • 14. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
    Garrido-Sánchez L, Cardona F, García-Fuentes E, Rojo-Martínez G, Gómez-Zumaquero JM, Picón MJ, Soriguer F, Tinahones FJ.
    Eur J Clin Invest; 2008 Sep 01; 38(9):615-21. PubMed ID: 18837736
    [Abstract] [Full Text] [Related]

  • 15. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J, Jeyasekharan AD, Theunissen R, Tervaert JW.
    Ann N Y Acad Sci; 2005 Jun 01; 1050():163-9. PubMed ID: 16014530
    [Abstract] [Full Text] [Related]

  • 16. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Jun 01; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 17. Antibody against oxidized low-density lipoprotein predicting myocardial infarction.
    Puurunen M, Mänttäri M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T.
    Arch Intern Med; 1994 Nov 28; 154(22):2605-9. PubMed ID: 7979858
    [Abstract] [Full Text] [Related]

  • 18. Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and myocardial infarction.
    Wu R, Shen G, Morris R, Patnaik M, Peter JB.
    J Autoimmun; 2005 Jun 28; 24(4):353-60. PubMed ID: 15913955
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A, Young IS, Wisdom GB.
    J Pharm Pharmacol; 2002 Dec 28; 54(12):1651-7. PubMed ID: 12542895
    [Abstract] [Full Text] [Related]

  • 20. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec 28; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.